CERO (CERo Therapeutics Holdings) FCF Yield % : -59.56 (As of Apr. 01, 2025)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CERo Therapeutics Holdings's Trailing 12-Month Free Cash Flow is $-1.32 Mil, and Market Cap is $2.21 Mil. Therefore, CERo Therapeutics Holdings's FCF Yield % for today is -59.56%.

The historical rank and industry rank for CERo Therapeutics Holdings's FCF Yield % or its related term are showing as below:

CERO' s FCF Yield % Range Over the Past 10 Years
Min: -61.39 Med: 0 Max: 0
Current: -59.56

CERO's FCF Yield % is ranked worse than
76.3% of 1498 companies
in the Biotechnology industry
Industry Median: -15.025 vs CERO: -59.56

CERo Therapeutics Holdings's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

CERo Therapeutics Holdings FCF Yield % Historical Data

The historical data trend for CERo Therapeutics Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings FCF Yield % Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

FCF Yield %

CERo Therapeutics Holdings Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of CERo Therapeutics Holdings's FCF Yield %

For the Biotechnology subindustry, CERo Therapeutics Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CERo Therapeutics Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CERo Therapeutics Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CERo Therapeutics Holdings's FCF Yield % falls into.

Save Embed

;

Save Embed

;

CERo Therapeutics Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CERo Therapeutics Holdings's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-12.403	/	0
	=	N/A%

CERo Therapeutics Holdings's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	13.76175
	=	0.00%

CERo Therapeutics Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

CERo Therapeutics Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, South San Francisco, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.